InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Adams Adrian, Director. Insider active across 5 companies, notably Akebia Therapeutics, Inc.. Aggregated, 14 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €203k. Activity tracked since 2 June 2021. The latest transaction was filed on 23 October 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Adams Adrian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
5,100 sharesCommon StockSEC:0001248144-26-000003:0
35,700 sharesCommon StockSEC:0001248144-26-000001:0
4,267 shares0Common StockSEC:0001248144-25-000004:0
35,700 shares0Common StockSEC:0001562180-25-004723:0
2,174 shares0Common StockSEC:0001415889-24-018074:0
30,000 shares0Common StockSEC:0001562180-24-004901:0
581 shares0Common StockSEC:0001209191-23-058474:0
30,000 shares0Common StockSEC:0001562180-23-004956:0
15,500 shares0Common StockSEC:0001209191-22-042308:0
13,700 shares0Common StockSEC:0001562180-22-004973:0
17,203 shares@ US$13.8061100.0% of flowCommon StockSEC:0001209191-21-052595:0
Canonical exit: 16 Nov 2021 (T+90)
10,000 shares0Common StockSEC:0001209191-21-041579:0
13,700 shares0Common StockSEC:0001562180-21-004026:0
2,944,888 sharesCommon SharesSEC:0001104659-16-095179:0
14 of 14 declarations
About Adams Adrian
ADAMS ADRIAN is Administrateur, Président et Directeur Général. He has 14 filings in total, and across the 14 most recent filings available, the buy amount is EUR 202940, the sell amount is EUR 0, with a date range from 2016-02-09 to 2026-06-24. His listed companies are Akebia Therapeutics, Inc., TALPHERA, INC., Acelrx Pharmaceuticals INC, Impel Neuropharma INC and Aralez Pharmaceuticals Inc.
